GlobeNews Wire

1314 Articles

Press Release: ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP

ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3…

GlobeNews Wire GlobeNews Wire

Merus Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC

Petosemtamab in combination with pembrolizumab in 1L r/m PD-L1 expressing HNSCC ongoing…

GlobeNews Wire GlobeNews Wire

Fobi AI Provides Clarification On Total Holdings Previously Provided In The Companys Information Circular

December 06, 2024 20:43 ET | Source: Fobi AI Inc. VANCOUVER, British…

GlobeNews Wire GlobeNews Wire

Fobi AI Provides Update on Current Cease Trade Order

December 06, 2024 20:34 ET | Source: Fobi AI Inc. VANCOUVER, British…

GlobeNews Wire GlobeNews Wire

Voxtur Announces Amendments to Financial Statements and MD&A forQ3 Ended September 30, 2024

December 06, 2024 18:16 ET | Source: Voxtur Analytics Corp. TORONTO and…

GlobeNews Wire GlobeNews Wire

Cerence AI Announces Equity Grant to Employee Under Inducement Plan Pursuant to Nasdaq Listing Rule 5635(c)(4)

BURLINGTON, Mass., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC)…

GlobeNews Wire GlobeNews Wire

VivoPower to host Annual General Meeting on December 30, 2024 in London

London, Dec. 06, 2024 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ: VVPR)…

GlobeNews Wire GlobeNews Wire